Healthcare App Development in Australia: TGA Compliance, Speed, and Founder Mistakes
If the founders of a healthcare app rapid development in Australia attempt a healthcare app rapid development, the one obstacle that hinders them is taking TGA compliance as a last step in the build phase. They scope the product, they build it, they prepare it for launch, and then they find that their medical app development in Australia project needs to be registered on the Australian Register of Therapeutic Goods (ARTG), or undergo a conformity assessment or major architectural changes in order to comply with the Privacy Act 1988. The delays that follow when the product is launched are a result of other factors and not complexity. They result from sequencing.
In this guide, you'll find out what TGA actually regulates, how to classify your app before you start coding, how Privacy Act requirements affect architecture decisions, and how to structure a healthcare app rapid development in Australia for compliance to be built in, not bolted on.
What the TGA Regulates and why it matters in 2026
Australian's main regulatory body for medical devices and therapeutic goods is the Therapeutic Goods Administration. Software can be classified as a medical device under the Therapeutic Goods Act 1989 (TGAct89) if it serves a medical purpose but is not a physical device.Software is a medical device, and therefore can be classified as Software as a Medical Device (SaMD), under TGAct89 if it is used for a medical purpose without being a physical device. The definition of trigger is based on the software's intended use, not its technology, according to the TGA's own software and AI guidance.
The TGA has dedicated SaMD regulation Australia 2026-2027 as a priority enforcement focus area. Founders constructing in this area must plan for compliance in the first sprint; this is more rigorous than ever in Australia's digital health history.
What is SaMD and will my app be considered?
SaMD is a software with a medical function that is not embedded in a physical device and that enables the performance of a medical function without the presence of a medical device. Any information that is independently provided or made to a clinical decision made by your healthcare app about a particular patient is likely to be SaMD. When it doesn't generate clinical outputs, such as when it is used for communication, administration, or general wellness, it will probably not be regulated by the TGA. If the logic is automated or opaque particularly like the one in AI-driven systems TGA compliance app development requirements become more likely.
The realistic test: Does a clinician have the ability to corroborate and overrule the software's output with his or her own clinical judgment? If so, the software might not be subject to more stringent SaMD regulation. The more the logic is vague or automated, especially in the case of AI systems the more likely it is that the regulation will take effect.
The Four Classification Tiers That Determine Your Compliance Obligations
How does TGA classify health-care apps? TGA classification is based on risk. Creating a sense of the compliance cost will depend on which tier is applicable before the build commences.
Excluded software. This usually includes patient communication platforms, appointment scheduling systems, practice management software, general wellness applications, and administrative software. The Australian Digital Health Agency offers advice on mHealth for unregulated apps, but this is not legislation, according to ICLG Digital Health Laws and Regulations Report Australia.
Class I (Low Risk) SaMD devices are classified as Class I (low risk) and have the least onerous regulatory requirements. Some Class I devices with a medical use but minimal risk of injuring the patient if they fail can be self-certified.
Class IIa and IIb (medium risk) devices must meet international standards such as IEC 62304 (software lifecycle) and ISO 14971 (risk management), and be listed on the Australian Register of Therapeutic Goods (ARTG) prior to supply. Most of the clinically oriented apps, such as real-time monitoring, clinical decision support, and diagnostic functions, are here.
Class III The level of conformity assessment is highest for Class III (high risk) devices. They are often software that make independent clinical decision making decisions which are critical to life.
There's one design choice that crops up the most to make classification “smart”: Automated alert or risk-scoring. The passive monitoring display may also be Class I. With the same product and an automated clinical alert based on that data, it is typically a Class IIa product. This needs to be done at scoping, NOT during launch.
Privacy Act Requirement: Three Obligations That Shape Architecture.
What are the implications of the Privacy Act for the architecture of healthcare app architecture in Australia?
The Privacy Act 1988 and the Australian Privacy Principles (APPs) have binding requirements that apply to any healthcare app development in Australia that collects, uses, or discloses personal information. The Technical Architecture is most relevant to three Australian Privacy
Principles:
APP 11: Security of personal information. All health data is to be secured to prevent misuse, interference, loss, and unauthorised access: data at rest is to be encrypted; data in transit is to be encrypted; access to health data is to be controlled by the individual's role; health data is to be audited; retention and deletion policies are to be documented. The Australian Institute of Health and Welfare reports that one of the most frequently reported breaches of Australian digital health compliance is data security failures. Not something that can be added on a later date, these are infrastructure choices which should be part of the architecture specification of any healthcare app rapid development in Australia.
Policy 6: Use or disclosure. Health information for one purpose (clinical decision support) may not be used for another (model training, marketing, research) without separate and explicit informed consent for each purpose. Consent architecture should be in-built in the product from the beginning.
APP 1 Transparency. An accurate privacy policy is required that describes data collection, use and storage is mandatory for any healthcare MVP Australia. The policy should be consistent with the data architecture in practice.
The My Health Record integration is an additional one: all products accessing and/or writing to Australia's national health record platform must comply with the My Health Records Act 2012 and the FHIR compliant API requirements. This is a scope/architecture decision, not a design/implementation; one FHIR integration should be planned during the requirements phase, not during the design/API phase.
What Is The Duration Of Tga Registration?
What is the time for TGA compliance app development in Australia?
Self-certification within the TGA's conformity assessment process is the quickest route for Class I medical devices. The period from conformity assessment to ARTG listing is usually several months to more than a year for Class IIa devices which need to be listed on ARTG. The only way to prevent that timeline from being a post build delay is to begin the regulatory assessment process at the same time as the start of any healthcare app rapid development in Australia and not after the development process.
The takeaway for healthcare app rapid development in Australia: finish the TGA classification analysis in week one of the engagement. If the product must be ARTG listed, then start the regulatory process during the development process, not after. If they are treated as consecutive activities, they will cause six-month post-build delays.
Building Compliance Into Healthcare App Rapid Development Australia
Can healthcare app rapid development Australia project move in a timely fashion without sacrificing compliance?
Yes, when three decisions are made BEFORE the build, not during or after.
Decision 1 TGA classification at scoping. Conduct a classification analysis of the desired features before deciding on scope. Scope decisions that result in the change of a feature from excluded to Class I or from Class I to Class IIa are regulatory scope decisions. Make them deliberately at scoping instead of mid-sprint to avoid costly rework in healthcare app development Australia.
Decision 2 Architecture for compliance in sprint one. Infrastructure is not a feature: Encryption, access controls, audit logging, consent management, and data retention. These are defined during the requirements phase and integrated into the product's commodity layer in a fast healthcare app rapid development in Australia. This layer is automatically generated by an AI-driven development framework, making it easy to deliver fast without incurring compliance debt.
Decision 3: My Health Record integration planned, but not found. FHIR integration is a launch requirement, and should be part of the initial API architecture. If it is a v2 feature, then the API needs to be designed to support this change without a rebuild. Discovering this in week four of a six-week in week 4 of a 6-week healthcare app rapid development Australia engagement is a timeline-killing scope change.
How Chirpn Approaches Healthcare App Rapid Development in Australia
One of Chirpn's top activity verticals in Australia is healthcare. Pathway Healthcare, a rural health network serving regional Australia, required a production-ready telehealth and clinical management solution on a fast timeline with all aspects of the data security architecture of the solution in place on launch day not after.
The compliance architecture was addressed at the requirements phase by Chirpn's Rapid Launch framework: data encryption, role based access control, audit logging and consent management were all defined in week one and then implemented as part of the AutoPATH commodity layer. This allowed the engineering team to concentrate on the clinical workflows that were particular to Pathway Healthcare's rural setting.
For every healthcare app that is deemed SaMD, Chirpn starts its development engagement with a TGA regulatory consultant and not as a follow-on. The regulatory classification is used to inform the scope of the features and the scope of the features is used to determine the build. It's their parallel processing that keeps a healthcare app rapid development engagement in Australia on track.
Disclaimer: This article provides general educational information only and does not constitute legal or regulatory advice. Consult a qualified TGA regulatory consultant before making compliance decisions for your product.
Frequently Asked Questions
Is there a requirement to get TGA approval for healthcare app in Australia?
No. The TGA only regulates software if it serves a medical purpose (diagnosis, monitoring, treatment or clinical decision support). Usually, apps that are used for communicating with patients, scheduling appointments, promoting health, or administrative purposes are not regulated by TGA. Classification is not founded on whether software collects health data or leverages AI but rather, on the purpose it serves.
What is SaMD and am I developing a SaMD app?
SaMD is the term for Software as a Medical Device. The TGA's definition of software that carries out a medical function autonomously, without being built into a physical device. If your app is making an independent decision or providing information that leads to a clinical decision relating to a particular patient, then it is probably SaMD and is subject to TGA regulation. The TGA has been prioritising SaMD for enforcement for 2026 and 2027, and it is now more important than ever to have the classification analysis done early.
How does the Privacy Act affect healthcare app architecture in Australia?
The Privacy Act 1988 and Australian Privacy Principles impose obligations on health information to be protected, used for a defined purpose and managed under a transparent privacy policy. This translates to encryption at rest and in transit, access control, audit logging, and consent management should be part of the original architecture – not v2. The consent of each use of health data also has to be specifically designed into the product from the outset.
How long does TGA registration take for a healthcare app?
The fastest route for Class I SaMD is via TGA conformity assessment procedures, self-certification. Class IIa and higher: When the product is classified as a Class IIa or greater, it must be fully conformed to IEC 62304 and ISO 14971 and will generally take several months to more than a year from full application to being listed. The regulatory process needs to be initiated along with development rather than after the launch, otherwise the regulatory process will be a post-launch delay.
